|Day Low/High||7.75 / 8.00|
|52 Wk Low/High||6.07 / 25.13|
Amgen's migraine prevention drug Aimovig is understood to be superior to Teva's Ajovy.
Ajovy is the second anti-calcitonin gene-related peptide (CGRP) drug approved by the FDA to prevent migraines.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York, NY.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has commenced tender offers (the " Offers") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $400 million (the "...
I expect deal volume to have a substantial uptick before the end of 2018 rolls around.
The regulatory agency has authorized the sale of the drugmaker's generic version of Mylan's EpiPen.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Regeneron Pharmaceuticals, Inc.
Warren Buffett's Berkshire Hathaway increases its stake in the drugmaker to 43.2 million shares from 40.5 million shares at the end of March.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.
The animal health market continues to be strong, and so is the outlook. Here are several plays on the space and why you should make them.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2018.
U.S. stock futures trade lower on Thursday,, sparked by a tougher stance on China tariffs from the White House; Tesla jumps as revenue tops forecasts; Starbucks partners with Alibaba for a delivery business in China.
Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) published its annual social impact report, highlighting achievements related to the two pillars that drive the Company's initiatives: building healthy communities and leading a responsible...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2018 financial results on Thursday, August 2, 2018 at 7:00 a.
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Uceris ®1 (budesonide) extended-release tablets, 9 mg, in the U.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced 23 abstracts, one late-breaking poster and three oral presentations of fremanezumab for the preventive treatment of migraine which will be presented at the American Headache...
Despite a growing trade war between the U.S, and China, drug officials in that country have pledged to try to stop the flow of fentanyl into the U.S.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a change in the clinical development program of fremanezumab in chronic cluster headache.
A healthcare bill supported on both sides of the aisle was held up until Sen. Chuck Grassley talked with pharma companies.
Following up on a pledge to accelerate generic drugs into the marketplace to stoke price competition, the agency signals pending reform of the Risk Evaluation and Mitigation Strategy.
Jim Cramer weighs in on Sirius XM Radio, Teva Pharmaceuticals, iQIYI, Blue Apron, Shopify, Incyte, E*Trade Financial and more.
Jim Cramer tells investors to keep their eyes open for companies making changes -- that's what's being rewarded.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today confirmed that the U.
Here's what you need to know now for Friday, May 18.
Aimovig is the first treatment approved by the agency to prevent migraines by blocking the calcitonin gene-related peptide receptor.
The Dow, S&P 500 and Nasdaq all rose on Wednesday.
Berkshire Hathaway hiked its stake in the drugmaker, which is undergoing a restructuring, to 40.5 million shares as of the end of March.
First bulleted paragraph, second sentence of release dated May 15, 2018 should contain the numbers 4.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.